Breaking News Instant updates and real-time market news.

REPH

Recro Pharma

$7.92 /

+0.38 (+5.04%)

07:18
12/10/18
12/10
07:18
12/10/18
07:18

Recro Pharma presents results from meloxicam IV study at PGA72

Recro Pharma announced a poster presentation highlighting intravenous, or IV, meloxicam's effect on platelet function at the PostGraduate Assembly in Anesthesiology, or PGA72. The poster describes results from an ex vivo study assessing the effects of various concentrations of IV meloxicam on platelet function compared to ketorolac and an untreated control. The 5mcg/mL concentration of IV meloxicam in this study corresponds to the maximum plasma levels following a 30mg dose in the clinical setting. Similarly, the 5mcg/mL concentration of ketorolac in this study corresponds to a 30mg and the 2.5mcg/mL dose corresponds to the 15mg dose in the clinical setting. In this study, blood samples provided by healthy volunteers were analyzed to determine closure time, or CT, following the addition of IV meloxicam and ketorolac at the previously mentioned concentrations to the blood plasma samples. The researchers conducted the analyses using a platelet function analyzer, a standard of care for platelet function testing, or CEPI, and two different reagents, collagen with epinephrine and collagen with adenosine diphosphate, or CADP. In the CEPI reagent analysis, a significant treatment effect was observed for changes in CT. No significant difference was observed in CT for the IV meloxicam treated samples versus the untreated control at any of the evaluated concentrations. When compared to untreated control, the ketorolac treated sample CT values were significantly prolonged in both the 2.5mcg/mL and the 5mcg/mL concentrations. All IV meloxicam concentration levels had a significantly shorter CT compared to the 2.5mcg/mL ketorolac concentration. All IV meloxicam concentration levels had numerically shorter CTs compared to the 5mcg/mL ketorolac concentration, though only the 10mcg/mL IV meloxicam concentration reached statistical significance. In the CADP reagent analysis, neither IV meloxicam nor ketorolac demonstrated a significant change in CT versus untreated control.

REPH Recro Pharma
$7.92 /

+0.38 (+5.04%)

05/25/18 Roth Capital
Roth Capital says Recro Pharma manufacturing alone worth more than current price
05/24/18 Piper Sandler
Recro Pharma price target lowered to $9 after 'baffling' CRL at Piper Jaffray
05/24/18 Janney Montgomery Scott
Recro Pharma price target lowered to $11 after CRL at Janney Capital
04/19/18 Berenberg
Recro Pharma initiated with a Buy at Berenberg

TODAY'S FREE FLY STORIES

Recommendations
Cloudflare price target raised to $48 from $29 at RBC Capital » 06:38
08/04/20
08/04
06:38
08/04/20
06:38
NET

Cloudflare

$42.56 /

+0.97 (+2.33%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NET Cloudflare
$42.56 /

+0.97 (+2.33%)

NET Cloudflare
$42.56 /

+0.97 (+2.33%)

07/30/20 Oppenheimer
Cloudflare price target raised to $55 from $35 at Oppenheimer
07/30/20 Baird
Cloudflare price target raised to $45 from $30 at Baird
07/28/20 Jefferies
Cloudflare upgraded to Buy from Hold at Jefferies
07/22/20 Needham
Cloudflare price target raised to $47 from $38 at Needham
NET Cloudflare
$42.56 /

+0.97 (+2.33%)

  • 13
    Sep
NET Cloudflare
$42.56 /

+0.97 (+2.33%)

NET Cloudflare
$42.56 /

+0.97 (+2.33%)

NET Cloudflare
$42.56 /

+0.97 (+2.33%)

Earnings
Sony sees FY21 net income Y510B, sales and operating revenue Y8.3T » 06:38
08/04/20
08/04
06:38
08/04/20
06:38
SNE

Sony

$81.29 /

+3.38 (+4.34%)

Sees FY operating income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

Earnings
EnPro reports Q2 adjusted EPS 54c, consensus 8c » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
NPO

EnPro

$48.20 /

+0.55 (+1.15%)

Reports Q2 revenue $247M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NPO EnPro
$48.20 /

+0.55 (+1.15%)

NPO EnPro
$48.20 /

+0.55 (+1.15%)

Recommendations
FirstEnergy price target lowered to $28.50 from $45 at Mizuho » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
FE

FirstEnergy

$29.19 /

+0.2 (+0.69%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

07/28/20 Morgan Stanley
FirstEnergy has 'overshot even bearish outcomes' in Ohio, says Morgan Stanley
07/22/20 Argus
FirstEnergy downgraded to Hold on bribery scandal at Argus
07/22/20 Argus
FirstEnergy downgraded to Hold from Buy at Argus
07/22/20 Barclays
FirstEnergy downgraded to Equal Weight from Overweight at Barclays
FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

Hot Stocks
Sony to repurchase Y100B of its own shares from Aug. 5 to March 31, 2021  06:37
08/04/20
08/04
06:37
08/04/20
06:37
SNE

Sony

$81.29 /

+3.38 (+4.34%)

 
ShowHide Related Items >><<
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

Upgrade
Natixis upgraded to Buy from Hold at Jefferies » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
NTXFY

Natixis

$0.00 /

+ (+0.00%)

Jefferies analyst Flora…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTXFY Natixis
$0.00 /

+ (+0.00%)

07/15/20 Jefferies
Jefferies downgrades Natixis to Hold on dividend, CIB concerns
07/15/20 Jefferies
Natixis downgraded to Hold from Buy at Jefferies
Hot Stocks
Option Care Health sees FY20 adjusted EBITDA $200M-$210M » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
OPCH

Option Care Health

$11.85 /

+0.09 (+0.77%)

Sees FY20 free cash flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
05/26/20 Canaccord
Option Care Health management meetings lifts optimism, says Canaccord
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

  • 22
    Jul
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

Hot Stocks
Zimmer Biomet saw incremental improvement in May, June » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Zimmer Biomet said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Upgrade
Deutsche Bank upgrades McKesson to Buy after 'solid' Q1 beat » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
MCK

McKesson

$159.78 /

+10.22 (+6.83%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

05:24 Today Deutsche Bank
McKesson upgraded to Buy from Hold at Deutsche Bank
07/08/20 Guggenheim
McKesson price target raised to $175 from $168 at Guggenheim
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

Earnings
Option Care Health reports Q2 EPS (4c), consensus (8c) » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
OPCH

Option Care Health

$11.85 /

+0.09 (+0.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
05/26/20 Canaccord
Option Care Health management meetings lifts optimism, says Canaccord
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

  • 22
    Jul
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

Earnings
Sony reports Q1 Y191.09 vs. Y121.78 last year » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
SNE

Sony

$81.29 /

+3.38 (+4.34%)

Reports Q1 revenue Y1.97T…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

Earnings
Bio-Techne reports Q4 adj. EPS $1.00, consensus 75c » 06:35
08/04/20
08/04
06:35
08/04/20
06:35
TECH

Bio-Techne

$279.15 /

+4.49 (+1.63%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TECH Bio-Techne
$279.15 /

+4.49 (+1.63%)

TECH Bio-Techne
$279.15 /

+4.49 (+1.63%)

07/15/20 Stephens
Bio-Techne downgraded to Equal Weight from Overweight at Stephens
05/27/20 Stifel
Bio-Techne downgraded to Hold from Buy at Stifel
05/14/20 Benchmark
Benchmark sees 'multiple ways to play COVID-19' for Bio-Techne, starts at Buy
05/14/20 Benchmark
Bio-Techne initiated with a Buy at Benchmark
TECH Bio-Techne
$279.15 /

+4.49 (+1.63%)

Upgrade
MTU Aero Engines upgraded to Buy from Hold at HSBC » 06:35
08/04/20
08/04
06:35
08/04/20
06:35
MTUAY

MTU Aero Engines

$0.00 /

+ (+0.00%)

HSBC analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTUAY MTU Aero Engines
$0.00 /

+ (+0.00%)

05:30 Today HSBC
MTU Aero Engines upgraded to Buy from Hold at HSBC
07/27/20 JPMorgan
MTU Aero Engines price target raised to EUR 107 from EUR 78 at JPMorgan
07/21/20 Exane BNP Paribas
MTU Aero Engines downgraded to Underperform from Neutral at Exane BNP Paribas
07/14/20 UBS
MTU Aero Engines price target raised to EUR 144 from EUR 128 at UBS
Earnings
Primoris sees FY20 EPS $1.60-$1.80, consensus $1.25  06:35
08/04/20
08/04
06:35
08/04/20
06:35
PRIM

Primoris

$16.82 /

+0.83 (+5.19%)

 
ShowHide Related Items >><<
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

PRIM Primoris
$16.82 /

+0.83 (+5.19%)

07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

Earnings
Epizyme reports Q2 EPS (58c), consensus (61c) » 06:35
08/04/20
08/04
06:35
08/04/20
06:35
EPZM

Epizyme

$14.40 /

+0.56 (+4.05%)

Reports Q2 revenue $2.5M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

06/19/20 Citi
Epizyme should be bought on any confusion over label, at Citi
06/18/20 Jefferies
Jefferies sees broad approval for Epizyme's Taz as 'fundamental positive'
06/02/20 Wedbush
Epizyme removed from Best Ideas List at Wedbush
04/01/20 Oppenheimer
Epizyme downgraded to Perform at Oppenheimer
EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

Earnings
Zimmer Biomet not providing FY20 guidance due to COVID-19 » 06:34
08/04/20
08/04
06:34
08/04/20
06:34
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Zimmer Biomet said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Hot Stocks
Primoris reports total backlog at June 30 of $3.5B  06:34
08/04/20
08/04
06:34
08/04/20
06:34
PRIM

Primoris

$16.82 /

+0.83 (+5.19%)

 
ShowHide Related Items >><<
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

PRIM Primoris
$16.82 /

+0.83 (+5.19%)

07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

Upgrade
Reliance Steel upgraded to Buy from Hold at Deutsche Bank » 06:34
08/04/20
08/04
06:34
08/04/20
06:34
RS

Reliance Steel

$101.14 /

+2.81 (+2.86%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RS Reliance Steel
$101.14 /

+2.81 (+2.86%)

RS Reliance Steel
$101.14 /

+2.81 (+2.86%)

07/29/20 Citi
Reliance Steel price target raised to $115 from $90 at Citi
05/13/20 KeyBanc
Reliance Steel downgraded to Sector Weight from Overweight at KeyBanc
04/24/20 Citi
Reliance Steel price target lowered to $90 from $125 at Citi
03/30/20 Goldman Sachs
Reliance Steel upgraded to Buy from Neutral at Goldman Sachs
RS Reliance Steel
$101.14 /

+2.81 (+2.86%)

Earnings
Primoris reports Q2 EPS 68c, consensus 29c » 06:33
08/04/20
08/04
06:33
08/04/20
06:33
PRIM

Primoris

$16.82 /

+0.83 (+5.19%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

PRIM Primoris
$16.82 /

+0.83 (+5.19%)

07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

Earnings
Zimmer Biomet reports Q2 adj. EPS 5c, consensus (73c) » 06:33
08/04/20
08/04
06:33
08/04/20
06:33
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Earnings
Bayer sees FY20 core EPS EUR6.70-EUR6.90 vs. prior EUR7.00-EUR7.20 view » 06:33
08/04/20
08/04
06:33
08/04/20
06:33
BAYRY

Bayer

$0.00 /

+ (+0.00%)

The company is now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Earnings
Bayer reports Q2 core EPS up 5.3% to EUR1.59 » 06:32
08/04/20
08/04
06:32
08/04/20
06:32
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Group sales in the second…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Earnings
WestRock reports Q3 adjuted EPS 76c, consensus 44c » 06:32
08/04/20
08/04
06:32
08/04/20
06:32
WRK

WestRock

$27.86 /

+1.02 (+3.80%)

Reports Q3 revenue $4.2B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRK WestRock
$27.86 /

+1.02 (+3.80%)

WRK WestRock
$27.86 /

+1.02 (+3.80%)

07/16/20 BofA
Packaging Corp. upgraded to Buy after better than expected data at BofA
07/16/20 BofA
International Paper upgraded to Buy after better than expected data at BofA
06/15/20 Morgan Stanley
WestRock initiated with an Equal Weight at Morgan Stanley
05/26/20 Deutsche Bank
WestRock price target lowered to $34 from $42 at Deutsche Bank
WRK WestRock
$27.86 /

+1.02 (+3.80%)

WRK WestRock
$27.86 /

+1.02 (+3.80%)

Upgrade
BMC Stock Holdings upgraded to Outperform from Neutral at Wedbush » 06:31
08/04/20
08/04
06:31
08/04/20
06:31
BMCH

BMC Stock Holdings

$28.48 /

+2.88 (+11.25%)

Wedbush analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMCH BMC Stock Holdings
$28.48 /

+2.88 (+11.25%)

BMCH BMC Stock Holdings
$28.48 /

+2.88 (+11.25%)

07/15/20 B. Riley FBR
BMC Stock Holdings price target raised to $25 from $23 at B. Riley FBR
06/18/20
Fly Intel: Top five analyst upgrades
06/18/20 Benchmark
Benchmark upgrades BMC Stock Holdings to Buy on rising housing market confidence
06/18/20 Benchmark
BMC Stock Holdings upgraded to Buy from Hold at Benchmark
BMCH BMC Stock Holdings
$28.48 /

+2.88 (+11.25%)

Upgrade
Lenzing AG upgraded to Hold from Sell at Deutsche Bank » 06:31
08/04/20
08/04
06:31
08/04/20
06:31
LNZNF

Lenzing AG

/

+

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LNZNF Lenzing AG
/

+

05/12/20 Deutsche Bank
Lenzing AG price target lowered to EUR 43 from EUR 57 at Deutsche Bank
03/16/20 Berenberg
Lenzing AG price target lowered to EUR 45 from EUR 55 at Berenberg
03/11/20 Berenberg
Lenzing AG upgraded to Hold from Sell at Berenberg

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.